Inventor · disambiguated record
Yufeng Jane Tseng
Also filed as: TSENG YUFENG J · TSENG YUFENG JANE
6 granted patents·6 pending applications·0 citations·filing 2010–2025
68Inventor score
Top patents by PatentIndex Score
12 records- 0177US2025157590A1Systems and methods for chemical toxicity predictionUNIV NAT TAIWAN·Filed 2024·Application pending·0 cites
- 0274US12312326B2Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitorsUNIV NAT TAIWAN·Filed 2022·Granted May 27, 2025·0 cites·7 claims
- 0372US12129242B2Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitorsUNIV NAT TAIWAN·Filed 2022·Granted Oct 29, 2024·0 cites·19 claims
- 0470US2025250249A1Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitorsTSENG YUFENG JANE·Filed 2025·Application pending·0 cites
- 0556US11370775B2Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitorsUNIV NAT TAIWAN·Filed 2017·Granted Jun 28, 2022·0 cites·10 claims
- 0653US2023018423A1Benzimidazole derivatives for treatment and/or prevention of diseases and disorders mediated by nlrp3YODA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0749US2013226549A1Structure-based fragment hopping for lead optimization and improvement in synthetic accessibilityTSENG YUFENG J·Filed 2013·Application pending·0 cites
- 0848USRE49340EUse of known compounds as D-amino acid oxidase inhibitorsTSENG YUFENG JANE·Filed 2015·Granted Dec 20, 2022·0 cites·13 claims
- 0944US8383662B2Bicyclic heteroaryl compoundsUNIV NAT CHIAO TUNG·Filed 2010·Granted Feb 26, 2013·0 cites·8 claims
- 1041US2011224205A1Use of curcumin or its analogues in cancer therapy utilizing epidermal growth factor receptor tyrosine kinase inhibitorUNIV NAT TAIWAN·Filed 2011·Application pending·0 cites
- 1138US9868975B2Use of known compounds as D-amino acid oxidase inhibitorsTSENG YUFENG JANE·Filed 2015·Granted Jan 16, 2018·0 cites·13 claims
- 1225US2018037871A1Cancer initiating cell and use thereofLING THAI YEN·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →